(BCRX) BioCryst - Performance 24.4% in 12m
BCRX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
20.35%
#19 in Peer-Group
Rel. Strength
73.68%
#2018 in Stock-Universe
Total Return 12m
24.43%
#41 in Peer-Group
Total Return 5y
76.97%
#18 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 43.9 |
| High / Low | USD |
|---|---|
| 52 Week High | 11.19 USD |
| 52 Week Low | 6.41 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 6.29 |
| Buy/Sell Signal +-5 | -0.56 |
| Support / Resistance | Levels |
|---|---|
| Support | 8.0, 7.6, 7.1, 6.4, 6.1 |
| Resistance |
12m Total Return: BCRX (24.4%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: BCRX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BCRX
| Total Return (including Dividends) | BCRX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -17.44% | 3.15% | 4.01% |
| 3 Months | 28.45% | 17.08% | 17.14% |
| 12 Months | 24.43% | -11.14% | 13.46% |
| 5 Years | 76.97% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | BCRX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -95.2% | 52.1% | 90.3% |
| 3 Months | 34.3% | 79.4% | 97.5% |
| 12 Months | 53.5% | -87.4% | 46.4% |
| 5 Years | -27.7% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th12.00 | -19.96% | -20.62% |
| 3 Month | %th61.50 | 9.71% | 9.65% |
| 12 Month | %th79.50 | 40.03% | 9.67% |
| 5 Years | %th92.00 | 126.76% | -16.81% |
FAQs
Does BioCryst (BCRX) outperform the market?
Yes,
over the last 12 months BCRX made 24.43%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months BCRX made 28.45%, while XBI made 17.08%.
Performance Comparison BCRX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
BCRX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.5% | -21.5% | 2.6% | 11% |
| US NASDAQ 100 | QQQ | -0.4% | -21.7% | 0.6% | 11% |
| German DAX 40 | DAX | -0.8% | -18.7% | -9.6% | -6% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.7% | -22% | -1.9% | 6% |
| Hongkong Hang Seng | HSI | -1.4% | -20.3% | -19.4% | -11% |
| India NIFTY 50 | INDA | 0.9% | -16.6% | 2.1% | 27% |
| Brasil Bovespa | EWZ | 3.7% | -16.8% | -12.5% | 23% |
BCRX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.9% | -19.2% | -0.7% | 1% |
| Consumer Discretionary | XLY | -1.4% | -20.8% | 10.3% | 6% |
| Consumer Staples | XLP | 1.6% | -17.3% | 3.5% | 17% |
| Energy | XLE | -3.4% | -21.6% | 10.1% | 22% |
| Financial | XLF | 1% | -20.1% | 0.3% | -1% |
| Health Care | XLV | -0.6% | -17.5% | 14.1% | 31% |
| Industrial | XLI | -0.9% | -21.9% | -3.3% | 1% |
| Materials | XLB | -1.1% | -21.9% | 1.9% | 20% |
| Real Estate | XLRE | -0.2% | -17.3% | 4.1% | 16% |
| Technology | XLK | -0.4% | -24.1% | -2.5% | 13% |
| Utilities | XLU | -0.5% | -20.1% | -1.5% | 4% |
| Aerospace & Defense | XAR | -1.1% | -24.3% | -17.4% | -25% |
| Biotech | XBI | -4.1% | -20.6% | 12.8% | 36% |
| Homebuilder | XHB | -3.5% | -26.2% | 9.2% | 26% |
| Retail | XRT | -0.4% | -20.7% | 7.4% | 18% |
BCRX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1.1% | -20.7% | 16.5% | 29% |
| Natural Gas | UNG | 1.3% | -11% | 28.6% | 26% |
| Gold | GLD | -0.6% | -17.7% | -15.3% | -14% |
| Silver | SLV | -4.8% | -23.8% | -19.5% | 2% |
| Copper | CPER | -10.8% | -32.4% | -17% | 1% |
BCRX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.4% | -17.4% | 7.9% | 29% |
| iShares High Yield Corp. Bond | HYG | 0.1% | -18.6% | 5.6% | 15% |